Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
Diabetes Res Clin Pract. 2023 Aug;202:110728. doi: 10.1016/j.diabres.2023.110728. Epub 2023 May 20.
To determine and compare the incidence of diabetes complications in Chinese with youth-onset type 2 and type 1 diabetes.
We conducted a population-based prospective cohort study, including 1,260 people with type 2 diabetes and 1,227 with type 1 diabetes diagnosed at age < 20 years who underwent metabolic and complication assessment in Hong Kong Hospital Authority between 2000 and 2018. They were followed for incident cardiovascular disease (CVD), end-stage kidney disease (ESKD) and all-cause death until 2019. Multivariable Cox regression analysis was applied to compare the risks of these complications in type 2 versus type 1 diabetes.
People with type 1 diabetes (median age: 20 years, median diabetes duration: 9 years) and type 2 diabetes (median age: 21 years, median diabetes duration: 6 years) were followed for a mean period of 9.2 and 8.8 years respectively. The risks of CVD (HR [95 % CI] 1.66 [1.01-2.72]) and ESKD (HR 1.96 [1.27-3.04]) but not death (HR 1.10 [0.72-1.67]) were higher in type 2 versus type 1 diabetes, adjusted for age at diagnosis, diabetes duration and sex. The association became nonsignificant with further adjustment for glycaemic and metabolic control. Youth-onset type 2 diabetes conferred mortality excess (standardized mortality ratio 4.15 [3.28-5.17]) to age- and sex-matched general population.
People with youth-onset type 2 diabetes had higher incidence rates of CVD and ESKD than type 1 diabetes. The excess risks in type 2 diabetes were removed after adjusted for cardio-metabolic risk factors.
确定并比较中国青少年起病的 2 型和 1 型糖尿病患者糖尿病并发症的发生率。
我们进行了一项基于人群的前瞻性队列研究,纳入了 2000 年至 2018 年期间在香港医管局接受代谢和并发症评估的 1260 名 2 型糖尿病患者和 1227 名 1 型糖尿病患者,这些患者的诊断年龄均小于 20 岁。随访至 2019 年,以记录心血管疾病(CVD)、终末期肾病(ESKD)和全因死亡的发生情况。采用多变量 Cox 回归分析比较 2 型与 1 型糖尿病患者发生这些并发症的风险。
1 型糖尿病患者(中位年龄:20 岁,中位糖尿病病程:9 年)和 2 型糖尿病患者(中位年龄:21 岁,中位糖尿病病程:6 年)的平均随访时间分别为 9.2 年和 8.8 年。在校正诊断年龄、糖尿病病程和性别后,2 型糖尿病患者发生 CVD(HR [95%CI] 1.66 [1.01-2.72])和 ESKD(HR 1.96 [1.27-3.04])的风险较高,但死亡风险(HR 1.10 [0.72-1.67])并无差异。进一步校正血糖和代谢控制情况后,这种关联不再具有统计学意义。与年龄和性别匹配的一般人群相比,青少年起病的 2 型糖尿病患者的死亡率过高(标准化死亡率比 4.15 [3.28-5.17])。
与 1 型糖尿病相比,青少年起病的 2 型糖尿病患者 CVD 和 ESKD 的发生率更高。校正心血管代谢危险因素后,2 型糖尿病患者的风险增加现象消失。